News
ViroCell Biologics has entered a manufacturing collaboration with AvenCell Therapeutics Inc., delivering a novel retroviral ...
Hosted on MSN29d
Retroviruses: How Viral DNA Impacts Our Genome - MSNHow To Clean Dirty Baking Sheets So They Look Brand New Ford workers told their CEO ‘none of the young people want to work here.’ So Jim Farley took a page out of the founder’s playbook ...
The cold sore-causing Herpes Simplex Virus (HSV-1) hijacks human cells and reconfigures its DNA within just an hour after infection, according to a new study that may help tackle the pathogen ...
ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy ...
The FDA has granted RMAT designation to detalimogene voraplasmid for the treatment of high-risk, BCG-unresponsive, NMIBC with CIS.
Four patients with infantile-onset Pompe’s disease received a single intravenous injection of an adeno-associated virus serotype 9 vector carrying codon-optimized complementary DNA encoding ...
Adeno-associated virus (AAV)–mediated gene therapy has emerged as a promising treatment for hemophilia B. Data on safety and durability from 13 years of follow-up in a cohort of patients who had ...
With FDA platform technology designation for its viral vector, SRPT can fast-track other therapies using the same gene-delivery method.
U.S. FDA Grants Platform Technology Designation to the Viral Vector Used in SRP-9003, Sarepta’s Investigational Gene Therapy for the Treatment of Limb Girdle Muscular Dystrophy Type 2E/R4 ...
There is a consistent need from researchers to manufacture a cGMP virus to support the advancement of gene therapies.
Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their research efforts around the adeno-associated virus (AAV) vectors used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results